ProShare Advisors’s HYPERION THERAPEUTICS INC COM STK (DE) HPTX Stock Holding History

ProShare Advisors’s Portfolio HPTX Stock Details HPTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-19,327	Closed	-$887K	–	1912
2015 Q1	$887K	Buy	19,327 +2,691	+16%	+$80.5K	0.01%	902
2014 Q4	$399K	Buy	+16,636	New	+$375K	﹤0.01%	1333
2014 Q2	–	Sell	-8,490	Closed	-$219K	–	2769
2014 Q1	$219K	Buy	+8,490	New	+$230K	﹤0.01%	2464
2013 Q4	–	Sell	-12,359	Closed	-$323K	–	2353
2013 Q3	$323K	Buy	+12,359	New	+$310K	0.01%	1852

ProShare Advisors's HPTX Position: Q2 2015 in Review

ProShare Advisors sold out of HYPERION THERAPEUTICS INC COM STK (DE) (HPTX) in Q2 2015, closing a stake of 19,327 shares — an estimated $887K sold.

ProShare Advisors first reported a position in HPTX in Q3 2013 and held it in 4 quarters. The position peaked at $887K in Q1 2015. 0 funds tracked by Wall St. Rank hold HPTX as of Q2 2015.

ProShare Advisors reported no remaining HYPERION THERAPEUTICS INC COM STK (DE) position as of Q2 2015 after selling out during the quarter.
ProShare Advisors sold 19,327 HYPERION THERAPEUTICS INC COM STK (DE) shares in Q2 2015, an estimated $887K.
ProShare Advisors first reported a position in HYPERION THERAPEUTICS INC COM STK (DE) in Q3 2013 and held it in 4 quarters.
ProShare Advisors's HYPERION THERAPEUTICS INC COM STK (DE) position peaked at $887K in Q1 2015.
0 funds tracked by Wall St. Rank held HYPERION THERAPEUTICS INC COM STK (DE) as of Q2 2015.

Based on ProShare Advisors's 13F filing for Q2 2015, filed 11 Aug 2015.